Cellular Reprogramming

Scope & Guideline

Transforming Insights into Breakthroughs in Biotechnology

Introduction

Immerse yourself in the scholarly insights of Cellular Reprogramming with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2152-4971
PublisherMARY ANN LIEBERT, INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2010 to 2024
AbbreviationCELL REPROGRAM / Cell. Reprogramm.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801

Aims and Scopes

The journal 'Cellular Reprogramming' primarily focuses on the innovative field of cellular reprogramming, emphasizing the conversion of somatic cells into pluripotent stem cells or other cell types. It encompasses a range of methodologies and applications, highlighting the intersection of stem cell biology, regenerative medicine, and therapeutic interventions.
  1. Cellular Reprogramming Techniques:
    The journal covers various methodologies for inducing cellular reprogramming, including the use of transcription factors, small molecules, and gene editing technologies like CRISPR/Cas9.
  2. Stem Cell Biology:
    Research on different types of stem cells, including induced pluripotent stem cells (iPSCs) and mesenchymal stem cells, is a core focus, particularly their differentiation potential and applications in regenerative medicine.
  3. Therapeutic Applications:
    The journal emphasizes the clinical potential of cellular reprogramming in treating diseases, including cancer, neurodegenerative disorders, and age-related conditions.
  4. Ethical Considerations:
    Exploration of the ethical implications surrounding cellular reprogramming and stem cell research, ensuring responsible advancement in the field.
  5. Interdisciplinary Collaborations:
    The journal features interviews and discussions with leading researchers, fostering interdisciplinary collaboration across fields such as developmental biology, genetics, and regenerative medicine.
Recent publications in 'Cellular Reprogramming' have highlighted several trending themes and emerging scopes that reflect the current interests and advancements in the field. These themes indicate a dynamic shift towards innovative and practical applications of cellular reprogramming.
  1. Aging and Cellular Rejuvenation:
    There is a growing focus on the role of cellular reprogramming in reversing age-related changes and rejuvenating aged tissues, underlining its potential in regenerative medicine.
  2. Gene Therapy and Editing Technologies:
    Recent articles highlight the integration of gene therapy and advanced editing technologies, such as base editing and CRISPR, as critical components in enhancing reprogramming efficiency and safety.
  3. Exosome and Extracellular Vesicle Research:
    Emerging studies on the roles of exosomes and extracellular vesicles derived from stem cells are gaining traction, suggesting their potential in cell communication and regeneration.
  4. Applications in Cancer Therapy:
    The application of cellular reprogramming techniques in cancer therapy is increasingly discussed, particularly how reprogrammed cells can be utilized for targeted treatments.
  5. Ethics and Public Policy:
    There is an emerging discourse around the ethical implications and regulatory frameworks of cellular reprogramming, reflecting a growing awareness of the societal impacts of this research.

Declining or Waning

As the field of cellular reprogramming continues to evolve, certain themes appear to be losing prominence in recent publications. The following areas reflect a declining focus within the journal's scope.
  1. Traditional Cloning Techniques:
    Earlier articles emphasized cloning methodologies, but recent trends show a shift towards innovative reprogramming methods, indicating that traditional cloning may be waning in favor of more advanced techniques.
  2. Basic Mechanistic Studies:
    While foundational mechanistic studies were prevalent in earlier publications, there is a noticeable decline in purely theoretical discussions as the journal increasingly prioritizes practical applications and therapeutic advancements.
  3. Limited Focus on Non-Mammalian Systems:
    Research involving non-mammalian model organisms has decreased, with a stronger emphasis now on mammalian systems and human applications, suggesting a narrowing of the scope towards clinically relevant studies.

Similar Journals

International Journal of Stem Cells

Catalyzing Innovations in Stem Cell Applications
Publisher: KOREAN SOC STEM CELL RESEARCHISSN: 2005-3606Frequency: 2 issues/year

The International Journal of Stem Cells is a distinguished peer-reviewed journal dedicated to advancing the field of stem cell research. Published by the Korean Society for Stem Cell Research, this journal has established itself as a vital source of high-quality research since its inception in 2008. Operating under the ISSN 2005-3606 and E-ISSN 2005-5447, the journal caters to a global audience, featuring works that span a diverse array of topics within Cell Biology and Developmental Biology. It is noteworthy that as of 2023, the journal is ranked Q3 in Cell Biology and Q2 in Developmental Biology, highlighting its growing influence and credibility in the scientific community. Given its commitment to facilitating open scientific communication, it is crucial for researchers, professionals, and students to engage with the rigorous research published in this journal as it profoundly impacts the understanding and application of stem cell science. With accessibility to a wealth of innovative studies, the International Journal of Stem Cells remains an indispensable resource for anyone interested in the transformative potential of stem cell research.

American Journal of Stem Cells

Elevating the discourse in stem cell research and developmental biology.
Publisher: E-CENTURY PUBLISHING CORPISSN: 2160-4150Frequency: 1 issue/year

American Journal of Stem Cells is a leading multidisciplinary publication dedicated to advancing the field of regenerative medicine and stem cell research. Published by E-CENTURY PUBLISHING CORP, this journal has gained recognition for its commitment to high-quality scientific contributions, achieving impressive rankings within the Scopus database, particularly in the areas of Biochemistry, Genetics and Molecular Biology, and Developmental Biology. With its focus on innovative research, the journal offers crucial insights and developments that appeal to researchers, professionals, and students alike. Although it is not an open-access journal, the American Journal of Stem Cells plays a pivotal role in disseminating impactful findings that define the future of cellular therapies and regenerative methodologies. The journal's past coverage from 2012 to 2017 reflects its dedication to advancing knowledge in key scientific disciplines, making it an essential resource for anyone engaged in the dynamic landscape of stem cell science.

Stem Cells and Cloning-Advances and Applications

Unlocking the Potential of Stem Cells and Cloning
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-6957Frequency: 1 issue/year

Stem Cells and Cloning-Advances and Applications is a leading peer-reviewed journal dedicated to the dynamic fields of stem cell research and cloning technologies. Published by DOVE MEDICAL PRESS LTD in New Zealand since 2008, this Open Access journal ensures that groundbreaking findings are accessible to a global audience. With a focus on innovative applications and advancements in cellular biology, the journal plays a pivotal role in disseminating knowledge within the scientific community. The journal currently holds an impact factor that reflects its influence, with notable rankings in both Cell Biology and Medicine (Miscellaneous), showcasing its interdisciplinary relevance. Researchers, professionals, and students alike benefit from the journal’s wide-ranging contributions, covering critical topics from regenerative medicine to genetic research. With a commitment to fostering collaboration and encouraging discussion in these cutting-edge domains, Stem Cells and Cloning-Advances and Applications continues to be a vital resource for advancing scientific inquiry and application.

DIFFERENTIATION

Unveiling the Secrets of Biological Differentiation
Publisher: ELSEVIER SCI LTDISSN: 0301-4681Frequency: 6 issues/year

DIFFERENTIATION is a respected peer-reviewed journal published by Elsevier Science Ltd, dedicated to advancing knowledge in the fields of Cancer Research, Cell Biology, Developmental Biology, and Molecular Biology. With an established history since 1973, the journal continuously explores the intricacies of cellular and molecular processes that govern differentiation in biological systems, thus playing a pivotal role in shaping contemporary research directions. Currently indexed in the Q3 quartile across multiple relevant categories, it provides a crucial platform for researchers to disseminate their findings and engage with the scientific community. DIFFERENTIATION does not offer open access, but it remains a valuable resource for academics seeking to enhance their understanding of the fundamental mechanisms that underpin life sciences. By fostering a rigorous dialogue among scientists, it contributes significantly to the ever-evolving landscape of biochemistry and genetics.

BMB Reports

Advancing the Frontiers of Biochemistry and Molecular Biology
Publisher: KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGYISSN: 1976-6696Frequency: 12 issues/year

BMB Reports is a distinguished open-access journal published by the Korean Society of Biochemistry & Molecular Biology since 2008, making significant contributions to the fields of biochemistry, molecular biology, and medicine. With a current impact factor that positions it in the Q2 category for Biochemistry and Q1 for Miscellaneous Medicine, this journal supports a wide dissemination of high-quality research findings, fostering robust dialogue among researchers, professionals, and students alike. Based in Seoul, South Korea, BMB Reports aims to publish innovative studies that advance our understanding of biochemical and molecular processes, thus shaping the future of health and medicine. The journal's commitment to open access enhances the visibility of its articles, allowing for greater accessibility and engagement in the scientific community. With notable rankings in both the Biochemistry and Molecular Biology categories, BMB Reports stands as a vital resource for those seeking to stay at the forefront of research in these rapidly evolving disciplines.

Regenerative Engineering and Translational Medicine

Advancing the Future of Regenerative Medicine
Publisher: SPRINGER HEIDELBERGISSN: 2364-4133Frequency: 4 issues/year

Regenerative Engineering and Translational Medicine is an esteemed academic journal published by Springer Heidelberg, focusing on the interdisciplinary fields of biomaterials, biomedical engineering, and cell biology. With an ISSN of 2364-4133 and an E-ISSN of 2364-4141, the journal has carved a niche for itself since its inception in 2015, showcasing cutting-edge research that bridges the gap between scientific findings and practical applications in regenerative medicine. As a recognized platform in its field, it is currently positioned within Q3 quartiles in biomaterials, biomedical engineering, and medicine (miscellaneous), with a Scopus ranking that reflects its growing influence among peers. The journal aims to disseminate high-quality, peer-reviewed articles that highlight advancements in regenerative engineering, further advancing both theoretical and applied research. Scholars and practitioners seeking to stay at the forefront of the ever-evolving landscape of regenerative health solutions will find invaluable insights and innovations within these pages. Join a community of leading thinkers and explore the journal's comprehensive research contributions, which are crucial for fostering partnerships between academia and industry in the quest for transformative medical solutions.

BIOCELL

Connecting Researchers for a Deeper Understanding of Life Sciences
Publisher: TECH SCIENCE PRESSISSN: 0327-9545Frequency: 12 issues/year

BIOCELL is a distinguished peer-reviewed journal dedicated to the field of Cell Biology, published by TECH SCIENCE PRESS. Since its inception in 1995, the journal has been at the forefront of disseminating innovative research, with converged publication years extending from 1995 to 2013 and from 2015 to 2024. Although it currently holds a Q4 ranking in the Cell Biology category according to the 2023 category quartiles, BIOCELL aims to foster advancements by providing a platform for researchers, professionals, and students to share their findings in biochemistry, genetics, and molecular biology. The journal is available in both print (ISSN: 0327-9545) and digital formats (E-ISSN: 1667-5746) and seeks to attract contributions that enhance scholarly dialogue and understandings of cellular mechanisms and innovations. With a commitment to quality research and critical discourse, BIOCELL plays an important role in nurturing the scientific community within Argentina and beyond, offering vital insights that contribute to the advancement of the life sciences.

NEUROCHEMISTRY INTERNATIONAL

Elevating Knowledge in the Realm of Neurochemistry
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0197-0186Frequency: 10 issues/year

NEUROCHEMISTRY INTERNATIONAL, published by Pergamon-Elsevier Science Ltd, offers a premier platform for researchers and professionals in the realms of cell biology and cellular and molecular neuroscience. Established in 1980 and continuing its passion for advancing the field, this esteemed journal enhances scientific collaboration with a notable 2023 Q2 ranking in both relevant categories, placing it among the top-tier publications in its discipline with a Scopus rank of 23/97 for Cellular and Molecular Neuroscience. With its focus on groundbreaking research, the journal provides a wealth of vital data and insights that drive forward our understanding of neurochemistry and its implications in health and disease. While not an Open Access journal, NEUROCHEMISTRY INTERNATIONAL is integral for professionals, academics, and students aiming to stay at the forefront of neurobiological research innovations, making significant contributions to both academia and clinical applications.

Journal of Stem Cells & Regenerative Medicine

Advancing the Future of Healing
Publisher: JOURNAL STEM CELLS & REGENERATIVE MEDICINEISSN: 0973-7154Frequency: 2 issues/year

The Journal of Stem Cells & Regenerative Medicine is a leading publication dedicated to the advancing field of stem cell research and regenerative medicine. Established in India and published by JOURNAL STEM CELLS & REGENERATIVE MEDICINE, this Open Access journal has been available since 2007, providing researchers and practitioners with free and unrestricted access to high-quality articles. With an ISSN of 0973-7154, the journal is indexed in Scopus, featuring a wide array of topics and insights into biochemistry, biotechnology, cell biology, and molecular biology, as denoted by its relevant quartile rankings. This journal is committed to bridging the gap between laboratory research and clinical applications, making significant contributions to the scientific community. The convergence of innovative studies from 2010 to 2024 positions it as an invaluable resource for those looking to stay at the forefront of stem cell and regenerative medicine research.

Current Stem Cell Research & Therapy

Transforming Medicine through Stem Cell Insights
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1574-888XFrequency: 8 issues/year

Current Stem Cell Research & Therapy, published by Bentham Science Publishers Ltd, is a leading journal dedicated to advancing the field of stem cell research. With an ISSN of 1574-888X and an E-ISSN of 2212-3946, this journal has been a valuable resource since its inception in 2006 and continues to broaden its scope through 2024. Recognized in the Q2 quartile for Medicine (miscellaneous) and ranked in the 66th percentile among its peers, the journal plays a crucial role in disseminating high-quality, peer-reviewed research that explores both the therapeutic and biological implications of stem cells. Located in the United Arab Emirates, Current Stem Cell Research & Therapy embraces a global audience of researchers, professionals, and students, providing a vibrant platform for discourse and innovation. While the journal offers subscription-based access, it remains committed to enhancing the scientific community's understanding of stem cell therapy and its applications across various medical fields.